FDA Approved: CERIANNA — Supplemental Application (GE Healthcare Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CERIANNA (fluoroestradiol F-18) from GE Healthcare Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CERIANNA (Fluoroestradiol F-18)

Snippet

SUPPL AP for CERIANNA (FLUOROESTRADIOL F 18)